For decades, genetic testing has been treated like the Crown Jewels of medicine - locked away, rarely touched, only brought out after every other option has been exhausted. You'd get referred to a geneticist somewhere near the end of a diagnostic odyssey that probably took years and left you more confused than when you started. Cool system, very chill, zero problems.
Except, obviously, massive problems.
The pedestal problem
As Fast Company reports, exome and genome sequencing have somehow kept their reputation as highly specialized, last-resort tools - even as the science, technology, and cost landscape has shifted dramatically. Patients have changed. Medicine has changed. The actual capability to run these tests has changed. The way doctors order them? Largely frozen in time.
Think about that for a second. We live in a world where you can order a consumer DNA test with a cheek swab and have results mailed to your house, yet clinical genomic testing is still treated like something you earn after years of diagnostic suffering.
Why this actually matters
This isn't just a bureaucratic frustration - it has real consequences for real people. When genetic testing only shows up late in a diagnostic journey, it means delays in treatment, misdiagnoses piling up, and patients bouncing between specialists while the answer might have been findable from the start.
Broader, earlier use of genomic sequencing could short-circuit that whole exhausting process. For conditions with a genetic basis - which is a lot of conditions, by the way - getting a genomic answer upfront changes everything about how care is planned and delivered.
So what's the hold-up?
The gap between what genomic testing can do and how it's actually used in practice is, to put it politely, embarrassing. It's a mix of legacy thinking, workflow inertia, and a medical culture that still treats genetics as a niche specialty rather than a foundational diagnostic tool.
The argument being made with increasing urgency is simple: genome and exome sequencing shouldn't be the last thing your doctor thinks of. They should be part of the early conversation, especially for patients with complex or undiagnosed conditions.
Taking genetic testing off its pedestal isn't about being reckless with powerful technology. It's about finally using powerful technology in a way that actually serves patients - which is, one would hope, the whole point.
